Quick Answer
Immuneering Corp reported Net Income of -$56.02 million for fiscal year 2025.
Immuneering Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$56.02M | +8.2% |
| 2024 | -$61.04M | -14.1% |
| 2023 | -$53.47M | -5.9% |
| 2022 | -$50.51M | -50.6% |
| 2021 | -$33.54M | -96.8% |
| 2020 | -$17.04M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.96M | -2.5% | -3.7% |
| June 30, 2025 | -$14.43M | -2.5% | +4.1% |
| March 31, 2025 | -$15.05M | -5.2% | -3.1% |
| September 30, 2024 | -$14.60M | -15.9% | -3.7% |
| June 30, 2024 | -$14.08M | -15.5% | +1.6% |
| March 31, 2024 | -$14.31M | -5.2% | -13.6% |
| September 30, 2023 | -$12.60M | +1.9% | -3.3% |
| June 30, 2023 | -$12.19M | -5.7% | +10.4% |
- Immuneering Corp showed an increase of +8.2% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Immuneering Corp’s net income has declined by 228.8% (from -$17.04 million to -$56.02 million).
- The most recent figure is from Immuneering Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: